Epidemiological Aspects of Cutaneous Leishmaniasis in Logar Afghanistan

Authors

  • Mohammad Naser Sabawoon Lecturers of Para-Clinic Department, Medical Faculty, Paktia University, Gardez, Afghanistan
  • Muhammad Shafi Sharif Lecturers of Para-Clinic Department, Medical Faculty, Paktia University
  • Mir Ziaurahman Mehrabi Lecturers of Para-Clinic Department, Medical Faculty, Paktia University

DOI:

https://doi.org/10.53555/ans.v7i1.1513

Keywords:

Leishmaniasis, cutaneous, control, Logar

Abstract

Leishmaniasis is a common zoonotic disease. Cutaneous leishmaniasis is an important health problem in many countries of the southern and eastern Mediterranean, with diversity of clinical manifestations from simple and single lesions to extensive lesions. Approximately, 90% of CL cases occur in Af­ghanistan, Algeria, Iran, Iraq, Saudi Arabia, Syria, Brazil, and Peru. The present study aimed to determine the epidemiological aspect of CL in logar Afghanistan during the 21 months of 2019 and 2020. This was a cross sectional retrospective descriptive record-based study. All cases of CL reported to PMLCP by state health departments from March 2019 to December 2020 were enrolled. This study included all patients of all age groups and both sexes with a clinical diagnosis of leishmaniasis. The statistical analysis was performed by using the EPI INFO software package 6.04 version. The percentages were calculated for the various parameters which were under study. In 21monts study period 2085 were new cases and 42were recurrent cases. Out of 2085 (100%) were males 1030(49.40%) and 1055(50.59%) were females. The majority cases (1789(85.80%) were ≤5years old ages. From all cases more (85.56%) were diagnosed clinically. Of the total 2085 patients, 1981 (95.01%) cured, 102(4.89%) not cured and (3.78%) had recurrence in spite treatment completion.  Major (81.53%) treatment rout was intra lesion or local in the site of lesion. However, the implementation of a program for controlling cutaneous leishmaniasis in Afghanistan since 2002 burden of the disease is still high in the country; it is seriously alarming for policy makers and managers of the health system in Afghanistan, indicating the presence of some problems in controlling the disease.

Downloads

Download data is not yet available.

References

1. World Health Organization (2018). Leishmaniasis. Media Centre. World Health Organization. http://www.who.int/mediacentre/factsheets /fs375/en/.
2. World Health Organization (2017). Global Health Observatory data repository. Leishmaniasis. World Health Organization. http://apps.who.int/gho/data/node.main.N TDLEISH?lang=en%5d%20Accessed .
3. World Health Organization.. Urbanization: an increasing risk factor for leishmaniasis. Wkly Epidemiol Rec. 2002;77(44):365–70.
4. Desjeux P. Leishmaniasis: current situation and new perspec¬tives. Comp Immunol Microbiol Infect Dis. 2004;27(5):305–18.
5. Salah AB, Kamarianakis Y, Chlif S, Alaya NB, Prastacos P. Zoonotic cutaneous leishmaniasis in central Tunisia: spatio temporal dy¬namics. Int J Epidemiol. 2007;36(5):991–1000.

6. Manzoor A. Cutaneous leishmaniasis. J Pak Assoc Dermatol 2005; 15: 161-71.

7. World Health Organisation, 2006. http://www.who.int/leishmaniasis/ leishmaniasis_maps/en/index2.html.
8. Murray H W, Berman J D, Davies C R, Saravia N G. Advances in leishmaniasis. Lancet 2005: 366: 1561–1577.
9. Coler R N, Reed S G. Second-generation vaccines against leishmaniasis. Trends Parasitol 2005: 21: 244–249.
10. Soto J, Toledo J T. Oral miltefosine to treat new world cutaneous leishmaniasis. Lancet Infect Dis 2007: 7: 7.
11- K. A. Weigle, C. Santrich, F. Martinez et al., “Epidemiology of cutaneous leishmaniasis in Colombia: a longitudinal study of the natural history, prevalence, and incidence of infection and clinical manifestations,” The Journal of Infectious Diseases, vol. 168,no.3,pp.699–708,1993.
12. Kassi M, Afghan AK, Rehman R, Kasi PM, 2008. Marring leishmaniasis: the stigmatization and the impact of cutaneous leishmaniasis in Pakistan and Afghanistan. PLoS Negl Trop Dis 2: e259.
13- Alavinia, S., Arzamani, K., Reihani, M., Jafari, J., 2009. Some epidemiological aspects of cutaneous leishmaniasis in Northern Khorasan Province, Iran. Iran. J.
Arthropod.Borne Dis. 3 (2), 50.

Downloads

Published

2021-02-28

How to Cite

Sabawoon, M. N., Sharif, M. S., & Mehrabi, M. Z. (2021). Epidemiological Aspects of Cutaneous Leishmaniasis in Logar Afghanistan. International Journal For Research In Applied And Natural Science, 7(1), 31–36. https://doi.org/10.53555/ans.v7i1.1513

Issue

Vol. 7 No. 1 (2021): International Journal For Research In Applied And Natural Science (ISSN: 2208-2085)

Section

Articles

License

Copyright (c) 2021 International Journal For Research In Applied And Natural Science (ISSN: 2208-2085)

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

In consideration of the journal, Green Publication taking action in reviewing and editing our manuscript, the authors undersigned hereby transfer, assign, or otherwise convey all copyright ownership to the Editorial Office of the Green Publication in the event that such work is published in the journal. Such conveyance covers any product that may derive from the published journal, whether print or electronic. Green Publication shall have the right to register copyright to the Article in its name as claimant, whether separately
or as part of the journal issue or other medium in which the Article is included.

By signing this Agreement, the author(s), and in the case of a Work Made For Hire, the employer, jointly and severally represent and warrant that the Article is original with the author(s) and does not infringe any copyright or violate any other right of any third parties, and that the Article has not been published elsewhere, and is not being considered for publication elsewhere in any form, except as provided herein. Each author’s signature should appear below. The signing author(s) (and, in